Cost-effectiveness of adjuvant atezolizumab versus best supportive care in the treatment of patients with resectable early-stage non-small cell lung cancer and overexpression of PD-L1
- Escudero-Vilaplana, V.
- Collado-Borrell, R.
- De Castro, J.
- Insa, A.
- Martínez, A.
- Fernández, E.
- Sullivan, I.
- Flores, A.
- Arrabal, N.
- Carcedo, D.
- Manzaneque, A.
ISSN: 1941-837X
Year of publication: 2023
Volume: 26
Issue: 1
Pages: 445-453
Type: Article